QuidelOrtho stock trades 70.3 percent below its 52-week high

Published on 09/25/2026 at 16:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

QuidelOrtho stock stood at USD 10.57 on Nasdaq on September 25, 2026, at 10:10 a.m. ET. Q2 revenue reached USD 630.9 million, up 2.8 percent year over year.

QDEL, US7476011036, Illustration mit AI erstellt.

QuidelOrtho stock (ISIN US7476011036) was trading at USD 10.57 on Nasdaq on September 25, 2026, at 10:10 a.m. ET, down 1.12 percent from the prior close. The quote put the shares 70.3 percent below their 52-week high of USD 35.58 and 6.6 percent above the 52-week low of USD 9.92. The valuation challenge is visible in the gap between the latest market value and the company's revised earnings outlook.

Stock sits near yearly floor

QuidelOrtho had a market capitalization of USD 720,778,754 as of September 25, 2026, while trading volume reached 356,351 shares at the same intraday snapshot. The stock's USD 10.57 price was USD 0.65 above the yearly low, but USD 25.01 below the yearly high.

The daily move was measured rather than a threshold breach: QDEL was down USD 0.12, or 1.12 percent, from the previous close of USD 10.69. For investors, the 52-week spread matters because the current price sits much closer to the low than to the high.

Guidance reset shapes valuation

Stock Titan reports that QuidelOrtho cut its fiscal 2026 revenue guidance to USD 2.52 billion-USD 2.60 billion on August 6, 2026, from an earlier USD 2.70 billion-USD 2.75 billion range. Adjusted EPS guidance was reduced to USD 0.65-0.90 from USD 1.80-2.00, while free cash flow guidance was withdrawn.

The second-quarter report supplied a brighter comparison. Revenue reached USD 630.9 million in the quarter ended June 28, 2026, up 2.8 percent year over year, while GAAP net loss was USD 92.9 million, or USD 1.36 per diluted share, according to Stock Titan.

Analysts keep targets above price

J.P. Morgan analyst Casey Woodring maintained a Sell rating and a USD 12.00 price target on August 25, 2026, as reported by The Globe and Mail. The same report cited a USD 15.00 average analyst target, placing that consensus USD 4.43 above the September 25 price.